Skip to content
Open access · CC-BY via OpenAlex

The Interplay Between Immunometabolism and Neuroinflammation in Alzheimer’s Disease

Tiziana Di Crescenzo, Giulio Papiri, Valentina Membrino, Sonila Alia, Monia Cecati, Roberto Campagna, Mauro Silvestrini, Simona Luzzi, Arianna Vignini

Biomolecules · 2026 · ▲ 3 citations

Abstract

Alzheimer’s disease (AD) is a multifactorial neurodegenerative disorder characterized by progressive cognitive decline and neuropathological hallmarks such as amyloid-β plaques and neurofibrillary tangles. In recent years, chronic neuroinflammation has emerged as a central mechanism linking genetic, metabolic, and immune dysfunctions in AD. Activated microglia and astrocytes release pro-inflammatory cytokines and reactive oxygen species that exacerbate synaptic and neuronal injury, while impaired clearance mechanisms and blood–brain barrier disruption further sustain inflammation. A growing body of research highlights the role of immunometabolism—the bidirectional interaction between immune activation and cellular metabolism—in shaping glial phenotypes and disease progression. Dysregulation of glucose, lipid, and amino acid metabolism, together with alterations in key metabolites such as lactate, NAD+, and reactive oxygen species, promotes a maladaptive inflammatory state. Genetic factors including APOE4 and TREM2 variants affect microglial lipid handling pathways, while systemic metabolic disorders and gut microbiota alterations amplify neuroinflammatory cascades. Natural bioactive compounds, particularly polyphenols, have gained attention for their ability to modulate immunometabolic pathways. By activating AMPK and SIRT1 and inhibiting mTOR(definition) and NLRP3 inflammasome signaling, polyphenols may tune mitochondrial function, redox homeostasis, and autophagy(definition), promoting adaptation to chronic metabolic stress. Therefore, metabolic-immune interactions represent pleiotropic therapeutic avenues for AD. Understanding how immunometabolites and nutrient-sensing pathways regulate compartmentalized inflammation in the CNS may pave the way for novel interventions that combine metabolic precision with neuroprotective efficacy.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.3390/biom16050656
Canonical
link ↗
Fetched
2026-11-14 MST

Cite this

APA
Crescenzo, T.D., Papiri, G., Membrino, V., Alia, S., Cecati, M., Campagna, R., Silvestrini, M., Luzzi, S., &amp; Vignini, A. (2026). The Interplay Between Immunometabolism and Neuroinflammation in Alzheimer’s Disease. <em>Biomolecules</em>. https://doi.org/10.3390/biom16050656
Vancouver
Crescenzo TD, Papiri G, Membrino V, Alia S, Cecati M, Campagna R, et al. The Interplay Between Immunometabolism and Neuroinflammation in Alzheimer’s Disease. Biomolecules. 2026. doi:10.3390/biom16050656.
BibTeX
@article{tiziana2026TheInt, title = {The Interplay Between Immunometabolism and Neuroinflammation in Alzheimer’s Disease}, author = {Tiziana Di Crescenzo and Giulio Papiri and Valentina Membrino and Sonila Alia and Monia Cecati and Roberto Campagna and Mauro Silvestrini and Simona Luzzi and Arianna Vignini}, journal = {Biomolecules}, year = {2026}, doi = {10.3390/biom16050656}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings